NPPG Administrator, Suite 213, Boundary House, London W7 2QE
Shortage Of Pancreatic Enzyme Replacement Therapy (PERT)
I am pleased to inform you that NPPG has published a position statement on the Shortage of Pancreatic Enzyme Replacement Therapy (PERT) in neonates and children. This has been written in response to National Patient Safety Alert
We hope that this position statement helps provide support on the key considerations when manging this shortage. This position statement aims to provide practical advice on using alternative products, dosing equivalences, and prescribing guidance,
I do hope that all organisations find the information contained in this position statement useful.
Chloe Benn (NPPG Vice Chair)
Keywords: PERT Pancreatin Pancreatic Enzyme Creon Nutrizym Pancrex